Intraoperative Signs and Treatment of Pulmonary Embolism Under General Anesthesia
The most critical early sign of intraoperative PE is a sudden decrease in end-tidal CO₂ (ETCO₂), which occurs before hemodynamic collapse, and immediate management requires UFH bolus, hemodynamic support with norepinephrine/dobutamine, and systemic thrombolysis for high-risk PE with shock. 1, 2
Intraoperative Signs of PE Under Anesthesia
The classic triad of dyspnea, anxiety, and tachypnea cannot be assessed in anesthetized patients, making monitoring parameters essential 3:
Primary Early Warning Sign
- Sudden decrease in ETCO₂ - This is the initial and most sensitive indicator, appearing before hemodynamic changes 2, 4
- Increased PaCO₂ with decreased ETCO₂ - This separation phenomenon (increased dead space) is highly suggestive of PE 4
Secondary Signs (Appear Later)
- Hypotension - sudden drop in blood pressure 5, 6
- Tachycardia - persistent and refractory to conventional treatment (fluids, analgesics, beta-blockers) 5, 3
- Hypoxemia/desaturation 2, 3
- Atrial fibrillation or other arrhythmias 5
- Hypercapnia on arterial blood gas 2, 5
Diagnostic Confirmation
- Transesophageal echocardiography (TEE) is the most valuable immediate diagnostic tool in the operating room, showing right ventricular dysfunction, paradoxical septal motion, and potentially visible emboli 2, 5, 4
- TEE provides crucial differential diagnosis and monitoring before CT pulmonary angiography can be obtained 2
Immediate Treatment Algorithm
Step 1: Hemodynamic Stabilization
For high-risk PE (shock present):
- Initiate UFH immediately with weight-adjusted bolus - do not delay for diagnostic confirmation 1
- Norepinephrine and/or dobutamine for hemodynamic support 1
- Aggressive IV fluid resuscitation and blood transfusion under continuous cardiac output monitoring 2
- If circulatory collapse occurs, initiate CPR immediately 5
Step 2: Risk Stratification
High-risk PE (hemodynamic instability/shock):
- Systemic thrombolytic therapy is the primary treatment 1
- If thrombolysis contraindicated or failed: surgical pulmonary embolectomy 1
- Alternative: percutaneous catheter-directed treatment 1
- ECMO may be considered in combination with surgical embolectomy or catheter-directed treatment for refractory circulatory collapse or cardiac arrest 1
Intermediate/Low-risk PE (hemodynamically stable):
- Continue anticoagulation with LMWH or fondaparinux (preferred over UFH for most patients) 1
- Rescue thrombolytic therapy if hemodynamic deterioration occurs 1
- Routine systemic thrombolysis is NOT recommended for intermediate/low-risk PE 1
Step 3: Surgical Decision-Making
The decision to continue or abort surgery depends on:
- PE severity and hemodynamic stability
- Surgical urgency and bleeding risk
- Anticoagulation can be started intraoperatively in some cases after multidisciplinary consultation 4
- IVC filter placement should be considered if anticoagulation is contraindicated due to ongoing surgery 1, 4
Critical Pitfalls to Avoid
Do not wait for CT confirmation before starting anticoagulation - initiate UFH based on clinical suspicion with ETCO₂ drop and TEE findings 1, 2
Do not dismiss persistent tachycardia as benign - refractory tachycardia despite conventional treatment should raise immediate suspicion for PE, even with negative preoperative imaging 5
Do not rely on preoperative negative CTPA - PE can develop intraoperatively, particularly in high-risk patients (immobilization, orthopedic/pelvic surgery, trauma, malignancy) 5
Do not use routine thrombolysis for stable patients - reserve for high-risk PE or rescue therapy for deterioration 1
Monitor ETCO₂ continuously - a sudden drop is your earliest warning and may precede hemodynamic collapse by significant time, allowing proactive intervention 2, 4
The 2019 ESC guidelines 1 provide the framework for treatment decisions, with recent case reports 2, 5, 4 consistently demonstrating that ETCO₂ monitoring combined with TEE provides the fastest pathway to diagnosis and treatment in the operating room setting.